Taro-Tofacitinib 5 mg – DIN 02511304
Taro-Tofacitinib is Tofacitinib Citrate 5 mg (tablet), sold in Canada. It is used for rheumatoid arthritis. It is supplied by Taro Pharmaceuticals Inc. We don't have a photo or description of what this pill looks like yet, so check the name and code on the box or bottle, and ask a pharmacist before taking it. Its official Health Canada listing links to the product monograph, which describes the tablets.
Sold in Canada
Tofacitinib Citrate 5 mg
- Brand
- Taro-Tofacitinib
- Strength
- 5 mg
- Used for
- Rheumatoid arthritis
- Form
- Tablet
- Manufacturer
- Taro Pharmaceuticals Inc
- Drug class
- Cancer medicine (kinase inhibitor)
- Sold in
- Canada
- DIN
- 02511304
Source: Health Canada's Drug Product Database. Last checked .
Report a mistake
What is Tofacitinib used for?
Tofacitinib is used for rheumatoid arthritis.
- Medicine type
- Cancer medicine (kinase inhibitor)
Official uses from the US prescribing label
Rheumatoid Arthritis
Tofacitinib extended-release tablets are indicated for the treatment of adult patients with moderately to severely active rheumatoid arthritis (RA), who have had an inadequate response or intolerance to one or more TNF blockers.
Limitations of Use
Use of tofacitinib extended-release tablets in combination with biologic disease-modifying antirheumatic drugs (DMARDs) or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.
Psoriatic Arthritis
Tofacitinib extended-release tablets are indicated for the treatment of adults with active PsA who have had an inadequate response or intolerance to one or more TNF blockers.
Limitations of Use
Use of tofacitinib extended-release tablets in combination with biologic DMARDs or with potent immunosuppressants such as azathioprine and cyclosporine is not recommended.
Ankylosing Spondylitis
Tofacitinib extended-release tablets are indicated for the treatment of adult patients with active ankylosing spondylitis (AS), who have had an inadequate response or intolerance to one or more TNF blockers.
Limitations of Use
Use of tofacitinib extended-release tablets in combination with biologic DMARDs or potent immunosuppressants such as azathioprine and cyclosporine is not recommended.
From the FDA-approved label on DailyMed (published Oct 05, 2026).
Doctors sometimes prescribe a medicine for other reasons too. If you are not sure what yours is for, ask your pharmacist.
Is this your medicine? Check the box
- The box or bottle shows DIN 02511304.
- It names Taro-Tofacitinib, Tofacitinib Citrate 5 mg.
- A loose pill is a different matter: without a description of its markings, a pharmacist has to confirm what it is.
Sold in Canada as Taro-Tofacitinib by Taro Pharmaceuticals Inc.
In Canada: prescription only.
Ingredients
Active: Tofacitinib (Tofacitinib Citrate)
Other Tofacitinib pills
- PFIZER JK110 Tofacitinib 10 mg Blue, round, 10 mm Used for rheumatoid arthritis
- PFIZER JKI10 Tofacitinib 10 mg Blue, round, 10 mm Used for rheumatoid arthritis
- T10 Tofacitinib 10 mg Blue, round, 10 mm Used for rheumatoid arthritis
- 1589 Tofacitinib 10 mg Green, round, 10 mm Used for rheumatoid arthritis
- T2 M Tofacitinib 10 mg Blue, round, 9 mm Used for rheumatoid arthritis
- TI 10 Tofacitinib 10 mg Blue, round, 10 mm Used for rheumatoid arthritis
- TC 10 Tofacitinib 10 mg Blue, round, 9 mm Used for rheumatoid arthritis
- N2 Tofacitinib 10 mg Blue, round, 10 mm Used for rheumatoid arthritis